Candel Therapeutics (CADL) had the highest return in April 2024 by a US stock with a market cap of $300M to $2B or a market cap of $10B+, returning 309.9%.

ASSET	MONTH	% RETURN
Candel Therapeutics (CADL)	April 2024	309.88%
POET Technologies (POET)	April 2024	107.58%
Yatsen (YSG)	April 2024	103.26%
Red Cat (RCAT)	April 2024	100%
Oruka Therapeutics (ORKA)	April 2024	96.07%
Canopy Growth (CGC)	April 2024	81.02%
Benitec Biopharma Ltd ADR (BNTC)	April 2024	64.72%
Cullinan Oncology LLC (CGEM)	April 2024	58.6%
Nektar Therapeutics (NKTR)	April 2024	56.99%
Janux Therapeutics (JANX)	April 2024	51.52%
Hycroft Mining (HYMC)	April 2024	47.77%
New Pacific Metals (NEWP)	April 2024	46.72%
Koninklijke Philips NV ADR (PHG)	April 2024	32.48%
Snap (SNAP)	April 2024	31.1%
Phibro Animal Health (PAHC)	April 2024	28.56%
CEA Industries (BNC)	April 2024	27.89%
Coupang LLC (CPNG)	April 2024	26.19%
BW LPG (BWLP)	April 2024	26.01%
Real Brokerage (REAX)	April 2024	24.92%
Lands’ End (LE)	April 2024	23.91%
ProKidney (PROK)	April 2024	23.65%
SNDL (SNDL)	April 2024	23.5%
LuxExperience (LUXE)	April 2024	23.27%
CorMedix (CRMD)	April 2024	23.07%
GrafTech International (EAF)	April 2024	21.13%